European Journal of Radiology
Volume 51 , Pages S31-S38 , June 2004

Contrast-enhanced ultrasound for extrahepatic lesions: preliminary experience

Received 1 March 2004 ,Revised 8 March 2004 ,Accepted 15 March 2004.

References 

  1. Huda W, Ravenel JG, Scalzetti EM. How do radiographic techniques affect image quality and patient doses in CT?. Semin Ultrasound CT MR. 2002;23:411–422
  2. Rozycki GS, Shackford SR. Ultrasound, what every trauma surgeon should know. J. Trauma. 1996;40:1–4
  3. Solbiati L, Martegani A, Leen E, Correas JM, Burns PN, Becker D. Contrast enhanced ultrasound of liver diseases. Italia: Springer–Verlag; 2003.
  4. Leen E, Horgan P. Ultrasound contrast agents for hepatic imaging with nonlinear modes. Curr. Probl. Diagn. Radiol. 2003;32:66–87
  5. Lencioni R, Cioni D, Crocetti L, et al.  Ultrasound imaging of focal liver lesions with a second-generation contrast agent. Acad. Radiol. 2002;9(Suppl 2):S371–S374
  6. Bauer A, Solbiati L, Weissman N. Ultrasound imaging with SonoVue: low mechanical index real-time imaging. Acad. Radiol. 2002;9(Suppl 2):S282–S284
  7. Quaia E, Stacul F, Bertolotto M, Locatelli M, Mucelli RP. Characterization of focal liver lesions with pulse inversion harmonic imaging (PIHI) using a second generation US contrast agent. Acad. Radiol. 2002;9(Suppl 2):S376–S379
  8. Leen E, Angerson WJ, Yarmenitis S, et al.  Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur. J. Radiol. 2002;41:200–206
  9. Basilico R, Blomley MJ, Harvey CJ, et al.  Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent?. Eur. J. Radiol. 2002;41:184–191
  10. Leen E. The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Eur. Radiol. 2001;11(Suppl 3):E27–E34
  11. Solbiati L, Tonolini M, Cova L, Goldberg SN. The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur. Radiol. 2001;11(Suppl 3):E15–E26
  12. Spinazzi A. Emerging clinical applications for contrast-enhanced ultrasonography. Eur. Radiol. 2001;11(Suppl 3):E7–E12
  13. Schneider M, Arditi M, Barrau M, et al.  A new ultrasonographic contrast agent based on sulphur hexafluoride-filled microbubbles. Invest Radiol. 1995;30:451–457
  14. Schneider M. Characteristics of SonoVue. Echocardiography. 1999;16:743–746
  15. Bokor D. Diagnostic efficacy of SonoVue. Am. J. Cardiol. 2000;86(4A):19G–24G
  16. Catalano O, Lobianco R, Sandomenico F, Siani A. Splenic trauma: evaluation with contrast-specific sonography and a second-generation contrast medium. Preliminary experience. J. Ultrasound Med. 2003;22:467–477
  17. Feuchtner G, Frauscher F, zur Nedden D, Noppelstaetter F, Klauser A, Peschel R. Evaluation of focal renal lesions with contrast enhanced ultrasonography (CEUS) using a new microbubble contrast agent (SonoVue). Eu Congress of Radiology. Book of abstracts B-0707; 2003.
  18. Robotti D, Ciancia B, Olivieri G, et al. Use of ultrasound contrast medium in Crohn’s disease: preliminary experience. European Congress of Radiology. Book of abstracts, C-0149; 2003.

PII: S0720-048X(04)00130-5

doi: 10.1016/j.ejrad.2004.03.028

European Journal of Radiology
Volume 51 , Pages S31-S38 , June 2004

Article Tools

* Image Usage & Resolution